Price
Financials
Standalone, Rs crore| Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 4.40 | 3.21 | 4.50 | 3.03 | 3.27 | 4.13 | 4.56 | 5.40 | 3.07 | 3.14 | 3.06 | 3.15 |
| Expenses | 4.18 | 2.99 | 4.20 | 2.86 | 3.03 | 3.83 | 4.27 | 5.06 | 2.89 | 3.00 | 2.96 | 2.84 |
| Operating Profit | 0.22 | 0.22 | 0.30 | 0.17 | 0.24 | 0.30 | 0.29 | 0.34 | 0.18 | 0.14 | 0.10 | 0.31 |
| OPM % | 5.00% | 6.85% | 6.67% | 5.61% | 7.34% | 7.26% | 6.36% | 6.30% | 5.86% | 4.46% | 3.27% | 9.84% |
| Other Income | 0.10 | 0.01 | 0.10 | 0.06 | 0.05 | 0.07 | 0.16 | 0.09 | 0.07 | 0.10 | 0.22 | 0.04 |
| Interest | 0.01 | 0.04 | 0.02 | 0.01 | 0.00 | 0.02 | 0.04 | 0.02 | 0.00 | 0.02 | 0.02 | 0.00 |
| Depreciation | 0.03 | 0.03 | 0.01 | 0.03 | 0.03 | 0.03 | 0.03 | 0.03 | 0.03 | 0.03 | 0.02 | 0.05 |
| Profit before tax | 0.28 | 0.16 | 0.37 | 0.19 | 0.26 | 0.32 | 0.38 | 0.38 | 0.22 | 0.19 | 0.28 | 0.30 |
| Tax % | 25.00% | 25.00% | 24.32% | 26.32% | 23.08% | 25.00% | 23.68% | 23.68% | 36.36% | 21.05% | 35.71% | 23.33% |
| Net Profit | 0.21 | 0.12 | 0.28 | 0.15 | 0.19 | 0.24 | 0.29 | 0.30 | 0.14 | 0.16 | 0.18 | 0.23 |
| EPS in Rs | 0.70 | 0.40 | 0.94 | 0.50 | 0.64 | 0.80 | 0.97 | 1.00 | 0.47 | 0.54 | 0.60 | 0.77 |
| Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 7.10 | 6.44 | 6.90 | 9.09 | 14.83 | 13.95 | 14.09 | 12.07 | 15.19 | 15.00 | 14.66 | 12.42 |
| Expenses | 6.82 | 6.08 | 6.45 | 8.57 | 14.07 | 13.03 | 13.01 | 11.31 | 14.28 | 14.01 | 13.89 | 11.69 |
| Operating Profit | 0.28 | 0.36 | 0.45 | 0.52 | 0.76 | 0.92 | 1.08 | 0.76 | 0.91 | 0.99 | 0.77 | 0.73 |
| OPM % | 3.94% | 5.59% | 6.52% | 5.72% | 5.12% | 6.59% | 7.67% | 6.30% | 5.99% | 6.60% | 5.25% | 5.88% |
| Other Income | 0.13 | 0.08 | 0.12 | 0.16 | 0.16 | 0.31 | 0.11 | 0.20 | 0.28 | 0.34 | 0.47 | 0.43 |
| Interest | 0.06 | 0.04 | 0.11 | 0.06 | 0.03 | 0.03 | 0.02 | 0.05 | 0.09 | 0.07 | 0.06 | 0.04 |
| Depreciation | 0.15 | 0.14 | 0.14 | 0.16 | 0.18 | 0.15 | 0.13 | 0.13 | 0.11 | 0.11 | 0.10 | 0.13 |
| Profit before tax | 0.20 | 0.26 | 0.32 | 0.46 | 0.71 | 1.05 | 1.04 | 0.78 | 0.99 | 1.15 | 1.08 | 0.99 |
| Tax % | 30.00% | 30.77% | 25.00% | 26.09% | 23.94% | 20.95% | 23.08% | 25.64% | 24.24% | 25.22% | 27.78% | |
| Net Profit | 0.14 | 0.18 | 0.25 | 0.35 | 0.55 | 0.83 | 0.80 | 0.58 | 0.75 | 0.87 | 0.78 | 0.71 |
| EPS in Rs | 0.47 | 0.60 | 0.84 | 1.17 | 1.84 | 2.78 | 2.68 | 1.94 | 2.51 | 2.91 | 2.61 | 2.38 |
| Dividend Payout % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| 10 Years | 5 Years | 3 Years | TTM | 1 Year | Last Year | |
|---|---|---|---|---|---|---|
| Compounded Sales Growth | 8% | 1% | 7% | -28% | ||
| Compounded Profit Growth | 19% | -1% | 10% | -30% | ||
| Stock Price CAGR | 18% | 13% | 2% | -8% | ||
| Return on Equity | 7% | 8% | 8% | 7% |
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 2.99 | 2.99 | 2.99 | 2.99 | 2.99 | 2.99 | 2.99 | 2.99 | 2.99 | 2.99 | 2.99 | 2.99 |
| Reserves | 2.50 | 2.64 | 2.82 | 3.07 | 3.42 | 3.97 | 4.80 | 5.61 | 6.18 | 6.93 | 7.80 | 8.58 |
| Borrowings | 0.09 | 1.13 | 0.01 | 0.13 | 0.20 | 0.29 | 0.04 | 0.00 | 0.96 | 0.00 | 3.90 | 0.08 |
| Other Liabilities | 1.37 | 1.43 | 1.37 | 0.97 | 1.73 | 2.30 | 1.43 | 2.66 | 1.27 | 0.89 | 1.60 | 0.95 |
| Total Liabilities | 6.95 | 8.19 | 7.19 | 7.16 | 8.34 | 9.55 | 9.26 | 11.26 | 11.40 | 10.81 | 16.29 | 12.60 |
| Fixed Assets | 1.26 | 1.11 | 1.02 | 1.19 | 1.30 | 1.14 | 1.00 | 0.88 | 0.89 | 0.80 | 0.88 | 0.88 |
| CWIP | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 1.75 |
| Investments | 1.82 | 2.15 | 2.70 | 3.15 | 4.04 | 5.29 | 3.11 | 4.06 | 3.39 | 3.34 | 3.87 | 4.45 |
| Other Assets | 3.87 | 4.93 | 3.47 | 2.82 | 3.00 | 3.12 | 5.15 | 6.32 | 7.12 | 6.67 | 11.54 | 5.52 |
| Total Assets | 6.95 | 8.19 | 7.19 | 7.16 | 8.34 | 9.55 | 9.26 | 11.26 | 11.40 | 10.81 | 16.29 | 12.60 |
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash from Operating Activity | 0.11 | 0.26 | 0.52 | 0.72 | 0.79 | 1.05 | -0.67 | 3.08 | -2.90 | 2.12 | -3.64 | 3.92 |
| Cash from Investing Activity | -0.34 | -0.28 | -0.55 | -0.69 | -1.06 | -1.15 | 2.45 | -0.93 | 0.59 | 0.13 | -0.67 | -2.24 |
| Cash from Financing Activity | -0.07 | 1.07 | -1.05 | 0.05 | 0.09 | 0.09 | -0.24 | 0.00 | 1.05 | -0.87 | 4.33 | -3.81 |
| Net Cash Flow | -0.29 | 1.05 | -1.08 | 0.08 | -0.19 | -0.01 | 1.54 | 2.14 | -1.25 | 1.38 | 0.02 | -2.13 |
| Free Cash Flow | 0.06 | 0.25 | 0.48 | 0.41 | 0.52 | 1.04 | -0.67 | 3.06 | -3.03 | 2.09 | -3.82 | 2.07 |
| CFO/OP | 35% | 93% | 144% | 160% | 152% | 138% | -73% | 285% | -382% | 233% | -368% | 509% |
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 60.51 | 96.65 | 96.35 | 43.38 | 47.38 | 32.24 | 39.77 | 13.99 | 54.43 | 16.82 | 46.23 | 25.15 |
| Inventory Days | 91.60 | 55.65 | 51.49 | 55.56 | 42.20 | 18.49 | 23.06 | 34.81 | 68.22 | 34.27 | 149.21 | 32.57 |
| Days Payable | 78.31 | 91.07 | 108.49 | 43.21 | 78.70 | 60.25 | 34.76 | 73.22 | 36.67 | 14.87 | 31.78 | 19.83 |
| Cash Conversion Cycle | 73.80 | 61.23 | 39.35 | 55.72 | 10.88 | -9.52 | 28.07 | -24.41 | 85.99 | 36.22 | 163.66 | 37.89 |
| Working Capital Days | 64.38 | 10.28 | 56.68 | 32.27 | 8.03 | -10.83 | 29.83 | -27.46 | 42.94 | 21.87 | 30.17 | 43.82 |
| ROCE % | 5.98% | 4.21% | 4.77% | 7.16% | 8.12% | 10.68% | 14.32% | 12.90% | 8.86% | 10.77% | 9.91% | 8.66% |
| Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Promoters | 49.38% | 49.38% | 49.42% | 49.80% | 49.80% | 49.85% | 49.91% | 49.92% | 49.96% | 50.04% | 50.04% | 50.04% |
| Public | 50.62% | 50.62% | 50.58% | 50.20% | 50.19% | 50.14% | 50.08% | 50.09% | 50.04% | 49.95% | 49.97% | 49.96% |
| No. of Shareholders | 5,134 | 5,283 | 5,351 | 5,272 | 5,555 | 5,412 | 5,398 | 5,341 | 5,320 | 5,263 | 5,194 | 5,146 |
Fundamentals
Market Cap₹ 21.5 Cr.
Current Price₹ 72.0
Stock P/E30.3
Book Value₹ 38.7
ROCE8.66 %
ROE6.98 %
Dividend Yield0.00 %
Face Value₹ 10.0
Compounded Sales Growth (TTM)-28%
Compounded Profit Growth (TTM)-30%
Standalone figures.
Valuation
Market capRs 23 Cr
Enterprise valueRs 20 Cr
P/E (TTM)32.09x
Price to book1.97x
Price to sales1.83x
EV / EBITDA17.09x
EV / EBIT19.21x
EV / sales1.62x
Price to cash flow5.81x
Earnings yield3.12%
P/E, 3-year average26.55x
P/B, 3-year average1.98x
P/E, 5-year average24.11x
P/B, 5-year average1.80x
Profitability
Operating margin (excl. other income)5.25%
Operating margin (incl. other income)8.46%
EBITDA margin9.50%
Pre-tax margin7.97%
Net profit margin5.72%
Net margin, latest quarter7.30%
ROE6.98%
ROCE8.66%
ROA5.40%
ROE, 3-year average7.75%
ROCE, 3-year average9.78%
ROA, 3-year average6.19%
ROE, 5-year average7.91%
ROCE, 5-year average10.22%
ROA, 5-year average6.30%
ROIC (approx.)8.47%
Tax rate27.78%
Other income / net worth4.06%
Growth
Sales growth (latest year)-2.27%
Profit growth (latest year)-10.34%
Sales CAGR, 3 years6.69%
Sales CAGR, 5 years1.00%
Profit CAGR, 3 years10.38%
Profit CAGR, 5 years-1.23%
Sales growth QoQ2.94%
Profit growth QoQ27.78%
Sales growth YoY (latest quarter)-41.67%
Profit growth YoY (latest quarter)-23.33%
Per share
EPS (TTM)Rs 2.37
EPS (latest year)Rs 2.61
EPS (latest quarter)Rs 0.77
EPS, 3-year averageRs 2.68
EPS, 5-year averageRs 2.53
Book value per shareRs 38.69
Sales per shareRs 41.53
Cash flow per shareRs 13.11
Free cash flow per shareRs 6.92
Efficiency
Asset turnover1.16x
Fixed asset turnover16.66x
Inventory turnover12.29x
Inventory days30 days
Debtor days25 days
Debtors turnover14.51x
Creditor days20 days
Cash conversion cycle38 days
Working capital days44 days
Leverage
Total debtRs 0 Cr
Cash and bankRs 3 Cr
Net debtRs -3 Cr
Debt to equity0.01x
Net debt / EBITDA-2.22x
Interest coverage17.50x
Owners' fund to total sources91.83%
Debt to assets0.63%
Cash flow
Cash from Operating Activity (latest year)Rs 4 Cr
Cash from Investing Activity (latest year)Rs -2 Cr
Cash from Financing Activity (latest year)Rs -4 Cr
Net Cash Flow (latest year)Rs -2 Cr
Free cash flow (latest year)Rs 2 Cr
FCFE (approx.: FCF + change in debt)Rs -2 Cr
Cash from ops / profit, 5 years0.68x
Sales to cash flow3.74x
Statement figures
Net sales (TTM)Rs 12 Cr
Net sales (latest year)Rs 15 Cr
Sales (latest quarter)Rs 3 Cr
Operating profit excl. other income (latest year)Rs 1 Cr
Operating profit (latest quarter)Rs 0 Cr
Other income (TTM)Rs 0 Cr
EBITDA (TTM)Rs 1 Cr
PBDT (TTM)Rs 1 Cr
Profit before tax (TTM)Rs 1 Cr
Tax (latest year)Rs 0 Cr
Net profit (TTM)Rs 1 Cr
Net profit (latest year)Rs 1 Cr
Net profit (latest quarter)Rs 0 Cr
Depreciation (TTM)Rs 0 Cr
Depreciation (latest quarter)Rs 0 Cr
Interest (TTM)Rs 0 Cr
Cost of goods sold (latest year)Rs 11 Cr
Total expenditure (latest year)Rs 14 Cr
Total income (latest year)Rs 15 Cr
Share capitalRs 3 Cr
ReservesRs 9 Cr
Shareholders' fundsRs 12 Cr
Total assetsRs 13 Cr
Net blockRs 1 Cr
Capital work in progressRs 2 Cr
InvestmentsRs 4 Cr
ReceivablesRs 1 Cr
InventoryRs 1 Cr
Other liabilitiesRs 1 Cr
Shares outstanding (crore)0.30
Ownership
Promoter holding50.04% (+0.12 in a year)
Computed by MarketFriction from the standalone statements. Returns use average balances.
P/E 32.1 is at the 78th percentile of its own 9.4-year range
(median 21.6, low 9.2, high 40.8).
P/B 1.97 is at the 65th percentile (median 1.66).
Monthly. Market cap from split-adjusted price; profit and book value as reported by that month. A low percentile means cheap versus its own history, not cheap versus peers.
| Period | 524400 | Nifty 50 | Difference |
|---|---|---|---|
| 1 week | +4.2% | -2.8% | +7.0 pts |
| 1 month | +3.0% | -6.8% | +9.8 pts |
| 3 months | +1.6% | -7.6% | +9.2 pts |
| 3 years | +11.8% | +14.2% | -2.4 pts |
| 5 years | +90.5% | +27.9% | +62.6 pts |
Red flags
F-score 7 of 8| look | Profit leans on other income Other income was 44% of pre-tax profit in 2026 |
Checks on the latest reported years: cash vs profit, accruals, receivables and inventory vs sales, dilution, debt, interest cover, equity, other income, losses, and auditor, top-management, insolvency and regulator filings in the last 12 months. A flag asks for an explanation; it is not a verdict.
Latest quarter
Jun 2026Sales ₹3 Cr -41.7% vs Jun 2025.
Net profit ₹0 Cr -23.3%.
Activity
Compare| Company | Mcap (Cr) | P/E | ROCE |
|---|---|---|---|
| Sun Pharmaceutical Industries Ltd | 447,476 | 35.4 | 20.5 % |
| Divis Laboratories Ltd | 250,363 | 84.0 | 22.0 % |
| Torrent Pharmaceuticals Ltd | 186,152 | 83.4 | 15.2 % |
| Zydus Lifesciences Ltd | 119,750 | 24.6 | 21.1 % |
| Cipla Ltd | 111,430 | 31.1 | 15.5 % |
| Laurus Labs Ltd | 106,928 | 97.8 | 17.8 % |
| Mankind Pharma Ltd | 105,120 | 49.3 | 13.5 % |
| Dr Reddys Laboratories Ltd | 104,494 | 32.4 | 13.0 % |
| Aurobindo Pharma Ltd | 97,682 | 25.8 | 12.9 % |
| Lupin Ltd | 93,840 | 15.8 | 29.9 % |
| Glenmark Pharmaceuticals Ltd | 68,905 | 22.1 | 39.8 % |
| Alkem Laboratories Ltd | 62,772 | 27.6 | 21.2 % |
| Biocon Ltd | 61,439 | 84.5 | 3.61 % |
| Abbott India Ltd | 57,949 | 35.9 | 44.8 % |
| Gland Pharma Ltd | 49,333 | 43.1 | 15.1 % |
No bulk or block deals on record.
No corporate actions on record.
No announcements in our files yet.
Company filings to NSE, newest first. Routine notices (trading window, newspaper copies) are left out. Click a row for the filing.
No short selling reported to NSE in our files.
Short sales disclosed by brokers to NSE, by trade date. Collected since late September 2026.
Not on any NSE surveillance list in the latest file.
Quick answers
What is the market cap of Ishita Drugs & Industries Ltd?
Ishita Drugs & Industries Ltd (524400) has a market capitalisation of Rs 21.5 Cr. at the 2026-10-01 close.
What is the P/E ratio of Ishita Drugs & Industries Ltd?
Ishita Drugs & Industries Ltd trades at a P/E of 30.3 on trailing twelve-month profit, at the 2026-10-01 close.
What were Ishita Drugs & Industries Ltd's latest quarterly results?
In the Jun 2026 quarter, Ishita Drugs & Industries Ltd sales was Rs 3 Cr (-41.7% vs Jun 2025) and net profit was Rs 0 Cr.